Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size, Share, Revenue, Trends And Drivers For 2024-2033

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033

LONDON, GREATER LONDON, UNITED KINGDOM, September 23, 2024 /EINPresswire.com/ — The sodium glucose cotransporter 2 (SGLT2) inhibitors market has experienced robust growth in recent years, expanding from $9.37 billion in 2023 to $10.17 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%.

The growth in the historic period can be attributed to early clinical trial successes, rising regulatory approvals, increasing diabetes diagnosis rates, and the demand for innovative diabetes treatments.

What Is The Estimated Market Size Of The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market And Its Annual Growth Rate?

The sodium glucose cotransporter 2 (SGLT2) inhibitors market is projected to continue its strong growth, reaching $14.19 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising diabetes prevalence, increasing obesity rates, growing awareness of diabetes management, and expanding applications in heart and kidney disease treatments.

Explore Comprehensive Insights Into The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market With A Detailed Sample Report:

Growth Driver Of The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

The increasing prevalence of diabetes is expected to propel the growth of the sodium glucose cotransporter 2 (SGLT2) inhibitor market going forward. Diabetes refers to a group of metabolic disorders characterized by high blood sugar levels resulting from defects in insulin secretion, insulin action, or both. The rise in diabetes cases can be attributed to factors such as urbanization, stress, environmental pollutants, and a lack of access to healthcare services. Sodium glucose cotransporter 2 (SGLT2) inhibitors are used in diabetes treatment to lower blood glucose levels by preventing glucose reabsorption in the kidneys, leading to its excretion in urine. They also offer cardiovascular and renal benefits, making them a valuable option for managing diabetes and its complications.

Explore The Report Store To Make A Direct Purchase Of The Report:

Which Market Players Are Driving the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Growth?
Key players in the sodium glucose cotransporter 2 (SGLT2) inhibitors market include Pfizer Inc., Johnson & Johnson Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmBH, Astellas Pharma Inc, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co. Ltd., Taisho Pharmaceutical Holdings Co. Ltd., Lupin Limited, Glenmark pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co. Ltd., Patsnap Synapse, Kotobuki pharmaceutical Co Ltd..

What Are the Emerging Trends Shaping the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview?
Major companies operating in the sodium glucose cotransporter 2 (SGLT2) inhibitor market are focused on developing dual inhibitor therapeutic solutions to improve patient outcomes and manage blood sugar levels. Dual inhibitor therapeutic solutions refer to treatments that simultaneously target two different sodium-glucose cotransporters (SGLT1 and SGLT2) to enhance efficacy in managing conditions such as heart failure and diabetes.

How Is The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Segmented?

1) By Type: Invokana, Jardiance, Farxiga Or Forxiga, Suglat
2) By Route Of Administration: Oral Route, Other Route Of Administration
3) By End User: Hospitals, Homecare Settings, Clinics

Geographical Insights: North America Leading The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market
North America was the largest region in the sodium glucose cotransporter 2 (SGLT2) inhibitors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sodium glucose cotransporter 2 (SGLT2) inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Definition
Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes by blocking the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion in urine. This helps lower blood glucose levels and can also contribute to weight loss and reduced blood pressure. They have additional cardiovascular and renal benefits, making them valuable in managing diabetic complications.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Global Market Report 2024 from TBRC covers the following information:

• Market size data for the forecast period: Historical and Future
• Macroeconomic factors affecting the market in the short and long run
• Analysis of the macro and micro economic factors that have affected the market in the past five years
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

An overview of the global sodium glucose cotransporter 2 (SGLT2) inhibitors market report covering trends, opportunities, strategies, and more

The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on sodium glucose cotransporter 2 (SGLT2) inhibitors market size, sodium glucose cotransporter 2 (SGLT2) inhibitors market drivers and trends, sodium glucose cotransporter 2 (SGLT2) inhibitors market major players, sodium glucose cotransporter 2 (SGLT2) inhibitors competitors’ revenues, sodium glucose cotransporter 2 (SGLT2) inhibitors market positioning, and sodium glucose cotransporter 2 (SGLT2) inhibitors market growth across geographies. The sodium glucose cotransporter 2 (SGLT2) inhibitors market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Sodium Reduction Ingredients Global Market Report 2024

Sodium Cocoyl Isethionate Global Market Report 2024

Sodium Lauryl Ether Sulfate [SLES] Global Market Report 2024

What Does The Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.